Cargando…
Anticoagulant Therapy in Patients with Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by the persistent positivity of antiphospholipid antibodies (aPLA) together with thrombosis or obstetrical complications. Despite their recognized predominant role, aPLA are not sufficient to induce the development of thr...
Autores principales: | Capecchi, Marco, Abbattista, Maria, Ciavarella, Alessandro, Uhr, Mario, Novembrino, Cristina, Martinelli, Ida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741036/ https://www.ncbi.nlm.nih.gov/pubmed/36498557 http://dx.doi.org/10.3390/jcm11236984 |
Ejemplares similares
-
Thrombotic Complications in Patients with Immune-Mediated Hemolysis
por: Capecchi, Marco, et al.
Publicado: (2021) -
Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients
por: Tripodi, Armando, et al.
Publicado: (2023) -
Successful Anticoagulation Therapy for Antiphospholipid Syndrome with Mobile Aortic Thrombi
por: Park, Hyun Oh, et al.
Publicado: (2016) -
Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings
por: Ferrari, Giorgia, et al.
Publicado: (2021) -
Adrenal Hemorrhage in a Patient Anticoagulated with Apixaban with Antiphospholipid Syndrome
por: Sanford, Zachary, et al.
Publicado: (2019)